Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2433
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorFLOR, Patricia B.-
dc.contributor.authorYAZBEK, Karina V. B.-
dc.contributor.authorIDA, Keila K.-
dc.contributor.authorFANTONI, Denise T.-
dc.date.accessioned2013-09-23T16:55:48Z-
dc.date.available2013-09-23T16:55:48Z-
dc.date.issued2013-
dc.identifier.citationVETERINARY ANAESTHESIA AND ANALGESIA, v.40, n.3, p.316-327, 2013-
dc.identifier.issn1467-2987-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2433-
dc.description.abstractObjective To test the effectiveness and safety of tramadol plus metamizole combined or not with a non-steroidal anti-inflammatory drug (NSAID) for treating moderate to severe chronic neoplastic pain in dogs, and its impact on quality of life (QL). Study design Prospective, uncontrolled, open-label, clinical study. Animals Sixty nine client-owned dogs with multiple forms of cancer and visual analog scale (VAS) pain score 40 after receiving NSAIDs for at least 7days. Methods The MN group received metamizole+NSAID, MNT group received metamizole+NSAID+tramadol and MT group received metamizole+tramadol. Pain was scored by the 0 to 100mm VAS (0=no pain, 100=worst pain) and analgesic therapy was considered effective if 25mm differences in VAS scores were observed between day 0 and the follow ups. The QL was evaluated according to a 0 to 36 scoring method for dogs (0=worst, 36=best) and side effects were recorded. Data were registered at day 0 (baseline) and at the first and second follow ups (7 and 14days after day 0, respectively). Results The MN group had less analgesia at day 7 (25%) and day 14 (42%) than MNT (59%, p=0.0274; 76%, p=0.0251, respectively) and MT groups (69%, p=0.0151; 81%, p=0.0341, respectively). The QL scores were lower in the MN group at the first (score 23) and second follow up (score 26) than in MNT (27, p=0.0847; 30, p=0.0002) and MT (28, p=0.0384; 31, p=0.0001) groups. Side effects were more commonly observed in the MN group (87%) than in MNT (24%, p<0.0001) and MT groups (25%, p=0.0003) at the first follow up. Conclusions and clinical relevance Tramadol plus metamizole combined or not with NSAID were well tolerated and clinically effective to treat moderate to severe pain in dogs with cancer and improved QL.-
dc.description.sponsorshipFundacao de Auxilio a Pesquisa do Estado de Sao Paulo - FAPESP [2004/04299-1]-
dc.language.isoeng-
dc.publisherWILEY-BLACKWELL-
dc.relation.ispartofVeterinary Anaesthesia and Analgesia-
dc.rightsrestrictedAccess-
dc.subjectanalgesia-
dc.subjectcanine-
dc.subjectdipyrone-
dc.subjectopioids-
dc.subjectpersistent pain-
dc.subjecttumors-
dc.subject.otherquality-of-life-
dc.subject.otheroral tramadol-
dc.subject.otherpostoperative pain-
dc.subject.otheranalgesic therapy-
dc.subject.otherdogs-
dc.subject.othermorphine-
dc.subject.otherquestionnaire-
dc.subject.othermanagement-
dc.subject.otherowners-
dc.subject.otherhydrochloride-
dc.titleTramadol plus metamizole combined or not with anti-inflammatory drugs is clinically effective for moderate to severe chronic pain treatment in cancer patients-
dc.typearticle-
dc.rights.holderCopyright WILEY-BLACKWELL-
dc.identifier.doi10.1111/vaa.12023-
dc.identifier.pmid23433180-
dc.subject.wosVeterinary Sciences-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalFLOR, Patricia B.:Univ Sao Paulo, Dept Cirurgia, Fac Med Vet & Zootecnia, BR-01246903 Sao Paulo, Brazil-
hcfmusp.author.externalYAZBEK, Karina V. B.:Univ Sao Paulo, Dept Cirurgia, Fac Med Vet & Zootecnia, BR-01246903 Sao Paulo, Brazil-
hcfmusp.description.beginpage316-
hcfmusp.description.endpage327-
hcfmusp.description.issue3-
hcfmusp.description.volume40-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84876402145-
hcfmusp.origem.idWOS:000318039400012-
hcfmusp.publisher.cityHOBOKEN-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceBenitez Del Rosario MA, 2002, ATEN PRIM, V29, P513-
hcfmusp.relation.referenceBrema F, 1996, INT J CLIN PHARM RES, V16, P109-
hcfmusp.relation.referenceBronden LB, 2003, VET REC, V152, P77-
hcfmusp.relation.referenceChandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.16248699-
hcfmusp.relation.referenceFlecknell P, 2008, BRIT J ANAESTH, V101, P121, DOI 10.1093/bja/aen087-
hcfmusp.relation.referenceFoley KM, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P981-
hcfmusp.relation.referenceFranklin MA, 2008, J AM ANIM HOSP ASSOC, V44, P342-
hcfmusp.relation.referenceFransson P, 2001, CANCER, V92, P3111, DOI 10.1002/1097-0142(20011215)92:12<3111::AID-CNCR10160>3.0.CO;2-E-
hcfmusp.relation.referenceGaynor JS, 2008, VET CLIN N AM-SMALL, V38, P1429, DOI 10.1016/j.cvsm.2008.06.009-
hcfmusp.relation.referenceHernandez-Delgadillo GP, 2003, EUR J PHARMACOL, V469, P71, DOI 10.1016/S0014-2999(03)01727-8-
hcfmusp.relation.referenceHielm-Bjorkman AK, 2009, AM J VET RES, V70, P727, DOI 10.2460/ajvr.70.6.727-
hcfmusp.relation.referenceImagawa VH, 2011, VET ANAESTH ANALG, V38, P385, DOI 10.1111/j.1467-2995.2011.00617.x-
hcfmusp.relation.referenceKneele KD, 1948, LANCET, V2, P6-
hcfmusp.relation.referenceKuKanich B, 2011, AM J VET RES, V72, P256, DOI 10.2460/ajvr.72.2.256-
hcfmusp.relation.referenceLamont LA, 2008, VET CLIN N AM-SMALL, V38, P1187, DOI 10.1016/j.cvsm.2008.06.002-
hcfmusp.relation.referenceLester P, 2000, VET CLIN N AM-SMALL, V30, P951-
hcfmusp.relation.referenceMartins TL, 2010, AM J VET RES, V71, P1019, DOI 10.2460/ajvr.71.9.1019-
hcfmusp.relation.referenceMastrocinque S, 2003, VET ANAESTH ANALG, V30, P220, DOI 10.1046/j.1467-2995.2003.00090.x-
hcfmusp.relation.referenceMathews KA, 2008, VET CLIN N AM-SMALL, V38, P1365, DOI 10.1016/j.cvsm.2008.09.001-
hcfmusp.relation.referenceMeldrum M, 2005, J PAIN SYMPTOM MANAG, V29, P41, DOI 10.1016/j.jpainsymman.2004.08.004-
hcfmusp.relation.referenceProschowsky HF, 2003, PREV VET MED, V58, P63, DOI 10.1016/S0167-5877(03)00010-2-
hcfmusp.relation.referenceRadbruch L, 1996, DRUG SAFETY, V15, P8, DOI 10.2165/00002018-199615010-00002-
hcfmusp.relation.referenceRaffa R, 1991, J PHARMACOL EXP THER, V260, P275-
hcfmusp.relation.referenceRobertson SA, 2002, J AM VET MED ASSOC, V221, P202, DOI 10.2460/javma.2002.221.202-
hcfmusp.relation.referenceSKAER TL, 1993, CLIN THER, V15, P638-
hcfmusp.relation.referenceSlater MR, 1996, J AM VET MED ASSOC, V208, P1248-
hcfmusp.relation.referenceSouza JFD, 2007, SUPPORT CARE CANCER, V15, P1319, DOI 10.1007/s00520-007-0327-7-
hcfmusp.relation.referenceVargas-Schaffer G, 2010, CAN FAM PHYSICIAN, V56, P514-
hcfmusp.relation.referenceWALSH TD, 1992, AM J CLIN ONCOL-CANC, V15, P268, DOI 10.1097/00000421-199206000-00018-
hcfmusp.relation.referenceWILDERSMITH CH, 1994, ANN ONCOL, V5, P141-
hcfmusp.relation.referenceWilliams HJ, 1997, CURR THER RES CLIN E, V58, P215, DOI 10.1016/S0011-393X(97)80018-5-
hcfmusp.relation.referenceWiseman ML, 2001, VET REC, V149, P423-
hcfmusp.relation.referenceWiseman-Orr ML, 2004, AM J VET RES, V65, P1077, DOI 10.2460/ajvr.2004.65.1077-
hcfmusp.relation.referenceWiseman-Orr ML, 2006, AM J VET RES, V67, P1826, DOI 10.2460/ajvr.67.11.1826-
hcfmusp.relation.referenceWithrow SJ, 2001, SMALL ANIMAL CLIN ON, P219-
hcfmusp.relation.referenceYazbek K. V. B., 2005, Brazilian Journal of Veterinary Research and Animal Science, V42, P250-
hcfmusp.relation.referenceYazbek KVB, 2005, JAVMA-J AM VET MED A, V226, P1354, DOI 10.2460/javma.2005.226.1354-
hcfmusp.relation.referenceZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.citation.scopus29-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - LIM/08
LIM/08 - Laboratório de Anestesiologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_IDA_Tramadol_plus_metamizole_combined_or_not_with_anti_2013.PDF
  Restricted Access
publishedVersion (English)314.45 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.